Hido Technologies Inc
Hido Technologies automates in-home medication delivery to reduce errors and hospital visits for people with chronic conditions. The company combines AI-driven software and a domestic robotics delivery system to monitor adherence, dispense doses, and alert caregivers or clinicians when issues arise. It is a hardware-plus-software healthcare solution used in home care and chronic disease management, supported by NIH/NIA-funded dementia research. The platform is deployed with healthcare providers, care agencies, and payers to lower acute utilization and support independent living.
Hido Technologies Inc
Hido Technologies automates in-home medication delivery to reduce errors and hospital visits for people with chronic conditions. The company combines AI-driven software and a domestic robotics delivery system to monitor adherence, dispense doses, and alert caregivers or clinicians when issues arise. It is a hardware-plus-software healthcare solution used in home care and chronic disease management, supported by NIH/NIA-funded dementia research. The platform is deployed with healthcare providers, care agencies, and payers to lower acute utilization and support independent living.
TL;DR
What they do: AI-enabled in-home medication dispensing and adherence monitoring (hardware + software)
Target customers: Medicare Advantage plans, payers, home-care programs and chronic care populations
Founders / leadership: Charles Gellman (Co‑Founder & CEO), Brandon Woolsey (Co‑Founder & CTO)
Founded: 2019
Total funding (reported): ≈ $1.55M (plus reported non-dilutive grants)
Company Overview
Problem Domain
Medication non-adherence and acute care utilization among people with chronic conditions receiving home care
Founded
2019
Industry
Biotechnology
Tech Stack
Funding Track Record
Early-stage financing reported; some sources also report non-dilutive grants (NIH/NIA) totaling additional funding not included in the equity amount
1550000
Reported last funding date and total funding amount in public profile
Investor Signal
“Right Side Capital Management, Startup Haven Ventures”